secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2026-06-12T20:05:29+00:00
Accession:  0001193125-26-269383
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immunome shareholders elect three Class III directors, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- James Boylan elected with 70.2M votes for, 22.2M withheld; Sandra Swain and Philip Wagenheim each received over 92M votes for.
- Ernst & Young ratified as independent auditor for FY 2026 with 104.1M votes for, 27,134 against.
- Advisory vote on executive compensation approved: 90.9M for, 1.4M against, 31K abstentions.
- Stockholders preferred annual advisory votes on exec compensation (91.9M for 1-year); company will hold annual votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000119312526269383/0001193125-26-269383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000119312526269383/imnm-20260609.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-269383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer